On the other hand, TP53 mutations without co-occurring STK11 or EGFR alterations (TP53-mut/STK11-EGFR-WT) identified the group of lung adenocarcinoma patients with high CD8+ T cell density. Here, TP53 is linked to lung adenocarcinoma.